Dynavax Technologies Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Dynavax Technologies Corp.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
/ 
Others were interested in
Frequently asked questions
To buy Dynavax Technologies Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Dynavax Technologies Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Dynavax Technologies Corp. is DVAX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Dynavax Technologies Corp. has its primary listing on NASDAQ. You can trade Dynavax Technologies Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Dynavax Technologies Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Dynavax Technologies Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Dynavax Technologies Corp..